FTC Settles With 'IV Cocktail' Seller Over Health Claims
The Federal Trade Commission told a company selling intravenous therapy products to cease marketing its iV Cocktails as alternative treatments for serious diseases without backing those claims with scientific and medical...To view the full article, register now.
Already a subscriber? Click here to view full article